103 related articles for article (PubMed ID: 11790654)
21. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.
Miller MK; Lee JH; Blanc PD; Pasta DJ; Gujrathi S; Barron H; Wenzel SE; Weiss ST;
Eur Respir J; 2006 Dec; 28(6):1145-55. PubMed ID: 16870656
[TBL] [Abstract][Full Text] [Related]
22. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
Smith MJ; Rascati KL; McWilliams BC
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):40-6. PubMed ID: 14756463
[TBL] [Abstract][Full Text] [Related]
23. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
Berger WE; Legorreta AP; Blaiss MS; Schneider EC; Luskin AT; Stempel DA; Suissa S; Goodman DC; Stoloff SW; Chapman JA; Sullivan SD; Vollmer B; Weiss KB
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):538-45. PubMed ID: 15609762
[TBL] [Abstract][Full Text] [Related]
24. A childhood asthma severity scale: symptoms, medications, and health care visits.
Ortega AN; Belanger KD; Bracken MB; Leaderer BP
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):405-13. PubMed ID: 11345283
[TBL] [Abstract][Full Text] [Related]
25. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
26. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with the control of severe asthma.
Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
[TBL] [Abstract][Full Text] [Related]
28. Asthma, from childhood to adulthood: a prospective 20-year longitudinal study of a cohort of asthmatics.
Nunes C; Ladeira S
J Investig Allergol Clin Immunol; 2002; 12(4):242-9. PubMed ID: 12926183
[TBL] [Abstract][Full Text] [Related]
29. Improving asthma outcomes in large populations.
Schatz M; Zeiger RS
J Allergy Clin Immunol; 2011 Aug; 128(2):273-7. PubMed ID: 21497885
[TBL] [Abstract][Full Text] [Related]
30. Asthma Severity in patients initiating controller monotherapy versus combination therapy.
Diette GB; Fuhlbrigge AL; Allen-Ramey F; Hopper A; Sajjan SG; Markson LE
J Asthma; 2011 Apr; 48(3):304-10. PubMed ID: 21391882
[TBL] [Abstract][Full Text] [Related]
31. Four of a kind: asthma control, FEV1, FeNO, and psychosocial problems in adolescents.
Tibosch M; de Ridder J; Landstra A; Hugen C; Brouwer M; Gerrits P; van Gent R; Roukema J; Verhaak C; Merkus P
Pediatr Pulmonol; 2012 Oct; 47(10):933-40. PubMed ID: 22328345
[TBL] [Abstract][Full Text] [Related]
32. Effects of an asthma management program on the asthmatic member: patient-centered results of a 2-year study in a managed care organization.
Buchner DA; Butt LT; De Stefano A; Edgren B; Suarez A; Evans RM
Am J Manag Care; 1998 Sep; 4(9):1288-97. PubMed ID: 10185979
[TBL] [Abstract][Full Text] [Related]
33. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.
Lanes SF; Lanza LL; Wentworth CE
Am J Respir Crit Care Med; 1998 Sep; 158(3):857-61. PubMed ID: 9731017
[TBL] [Abstract][Full Text] [Related]
34. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
35. Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs.
Farber HJ; Chi FW; Capra A; Jensvold NG; Finkelstein JA; Lozano P; Quesenberry CP; Lieu TA
Ann Allergy Asthma Immunol; 2004 Mar; 92(3):319-28. PubMed ID: 15049395
[TBL] [Abstract][Full Text] [Related]
36. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma.
Tomita K; Sano H; Iwanaga T; Ishihara K; Ichinose M; Kawase I; Kimura H; Hirata K; Fujimura M; Mishima M; Tohda Y
J Asthma; 2012 Apr; 49(3):253-9. PubMed ID: 22376075
[TBL] [Abstract][Full Text] [Related]
37. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S;
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462
[TBL] [Abstract][Full Text] [Related]
38. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease.
Chen H; Gould MK; Blanc PD; Miller DP; Kamath TV; Lee JH; Sullivan SD;
J Allergy Clin Immunol; 2007 Aug; 120(2):396-402. PubMed ID: 17561244
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
40. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community.
Armour C; Bosnic-Anticevich S; Brillant M; Burton D; Emmerton L; Krass I; Saini B; Smith L; Stewart K
Thorax; 2007 Jun; 62(6):496-502. PubMed ID: 17251316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
